Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Endocrine ; 14(2): 263-8, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11394645

RESUMO

It has been previously found that all hormone-producing phenotypes of the anterior lobe of the pituitary gland are capable of producing endothelin (ET)-like substances. The aim of this study was to determine whether the expression of ET-1-like peptides in lactotrophs, gonadotrophs, and somatotrophs is influenced by different in vivo ovarian hormonal conditions. Anterior lobes of the pituitary gland were harvested from ovariectomized and ovarian steroid-replaced adult female rats 10-12 d after surgery. Quantitative immunocytochemistry was performed on enzymatically dispersed pituitary cells. The presence of ET-1-like immunoreactivity in prolactin-, luteinizing hormone-, or growth hormone-producing cells was demonstrated by double-label immunocytochemistry. The incidence of ET-1 immunopositive pituitary cells was unaffected by progesterone treatment alone. Estradiol replacement caused a modest decrease in the number of lactotrophs and somatotrophs expressing ET-1 but increased the incidence of ET-1 immunopositive cells among gonadotrophs. Combined treatment with estradiol and progesterone robustly increased the incidence of ET-1 immunopositive lactotrophs and gonadotrophs but had no effect on somatotrophs. These data reveal that the synthesis of ET-1-like peptides in lactotrophs and gonadotrophs (and, to a lesser extent, in somatotrophs) is sensitive to ovarian steroids. Furthermore, these findings predict that ovarian steroids modulate ET-1 biosynthesis during the estrous cycle, suggesting a possible mechanism by which the ovarian steroid milieu may regulate the responsiveness of lactotrophs and gonadotrophs to their hypothalamic secretagogues.


Assuntos
Endotelina-1/análise , Estradiol/farmacologia , Hormônio do Crescimento/análise , Adeno-Hipófise/química , Progesterona/farmacologia , Prolactina/análise , Animais , Implantes de Medicamento , Estradiol/administração & dosagem , Feminino , Imunofluorescência , Hormônio Foliculoestimulante/análise , Imuno-Histoquímica , Hormônio Luteinizante/análise , Ovariectomia , Adeno-Hipófise/efeitos dos fármacos , Adeno-Hipófise/metabolismo , Progesterona/administração & dosagem , Ratos , Ratos Sprague-Dawley
2.
Brain Res ; 904(2): 259-69, 2001 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-11406124

RESUMO

Ample evidence indicates feedback relationships between pituitary prolactin and hypothalamic dopaminergic neurons. Since the presence of prolactin receptors was earlier demonstrated in hypothalamic dopaminergic neurons, our working hypothesis was that prolactin induced activation of prolactin receptor coupled signaling leads to increased neuronal activity in these neurons. The aim of this study was to correlate prolactin receptor mediated signaling and prolactin induced activation in hypothalamic dopaminergic neurons. We used nuclear translocation of STAT5 as a marker of prolactin receptor induced signaling and expression of Fos related antigens (FRAs) as an indicator of neuronal activation. We performed double label immunocytochemical studies to determine the time course of the presence of FRAs and STAT5 in the nuclei of hypothalamic dopaminergic neurons after ovine prolactin treatment. Exogenous ovine prolactin treatment of ovariectomized rats resulted in an increase in serum ovine prolactin levels and a decrease in endogenous serum prolactin levels, indicating that ovine prolactin activated mechanisms inhibited pituitary prolactin secretion. Indeed, ovine prolactin activated the prolactin receptors in most subpopulations of hypothalamic dopaminergic neurons, resulting in nuclear translocation of STAT5. Also, increased neuronal activity, indicated by expression of FRAs, was observed in the same neuron populations after ovine prolactin treatment. These results suggest that signal transduction mechanisms coupled to prolactin receptors in hypothalamic dopaminergic neurons resemble those observed in other tissues; and nuclear translocation of STAT5 can be used as a marker of prolactin receptor activation in hypothalamic dopaminergic neurons.


Assuntos
Proteínas de Ligação a DNA/metabolismo , Dopamina/metabolismo , Hipotálamo/metabolismo , Proteínas do Leite , Neurônios/metabolismo , Prolactina/sangue , Proteínas Proto-Oncogênicas c-fos/biossíntese , Transativadores/metabolismo , Transporte Ativo do Núcleo Celular/efeitos dos fármacos , Transporte Ativo do Núcleo Celular/fisiologia , Animais , Feminino , Hipotálamo/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Prolactina/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores da Prolactina/metabolismo , Fator de Transcrição STAT5 , Ovinos
3.
Endocrine ; 16(2): 133-7, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11887934

RESUMO

We have previously found that lactotrophs express and secrete endothelin-like peptides that influence prolactin (PRL) secretion in an autocrine fashion. We have also observed that the incidence of endothelin-immunoreactive lactotrophs is markedly affected by ovarian steroids. In this study, we examined how the ovarian steroid background determines the efficiency of the endothelin-mediated autocrine feedback regulation of PRL secretion. Ovariectomized adult female rats were used throughout these studies. Steroid replacements were made by sc implantation of Silastic capsules immediately following ovariectomy. Eight to 10 wk later, three animals from each treatment group (no steroid control, estradiol, progesterone, estradiol plus progesterone) were sacrificed by decapitation, and the anterior pituitary cells were enzymatically dispersed using collagenase and hyaluronidase. A PRL-specific reverse hemolytic plaque assay was used to measure PRL secretion at the single-cell level. BQ123, a synthetic cyclic pentapeptide with distinctive endothelin-A receptor antagonist quality, caused only a modest elevation of PRL secretion in the control group. Endothelin antagonism did not affect PRL secretion in cells obtained from progesterone-implanted animals. Endothelin antagonism did, however, increase overall PRL secretion in the estradiol and estradiol plus progesterone groups by five- and threefold, respectively. Frequency distribution of PRL plaques in these same two BQ123-treated groups revealed two subpopulations, indicating that lactotrophs differ in their response to endogenous endothelin feedback and that this difference is steroid dependent. These observations clearly suggest that the ovarian steroid milieu (estrogens in particular) can have a profound influence on the self-regulatory mechanisms of lactotrophs. Our results also emphasize that endogenous endothelins may play an important role in the negative feedback regulation of PRL secretion in female rats.


Assuntos
Comunicação Autócrina , Endotelinas/fisiologia , Prolactina/metabolismo , Animais , Combinação de Medicamentos , Antagonistas dos Receptores de Endotelina , Estradiol/farmacologia , Retroalimentação , Feminino , Ovariectomia , Peptídeos Cíclicos/farmacologia , Adeno-Hipófise/citologia , Adeno-Hipófise/efeitos dos fármacos , Adeno-Hipófise/metabolismo , Progesterona/farmacologia , Ratos , Ratos Sprague-Dawley
4.
Physiol Rev ; 80(4): 1523-631, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11015620

RESUMO

Prolactin is a protein hormone of the anterior pituitary gland that was originally named for its ability to promote lactation in response to the suckling stimulus of hungry young mammals. We now know that prolactin is not as simple as originally described. Indeed, chemically, prolactin appears in a multiplicity of posttranslational forms ranging from size variants to chemical modifications such as phosphorylation or glycosylation. It is not only synthesized in the pituitary gland, as originally described, but also within the central nervous system, the immune system, the uterus and its associated tissues of conception, and even the mammary gland itself. Moreover, its biological actions are not limited solely to reproduction because it has been shown to control a variety of behaviors and even play a role in homeostasis. Prolactin-releasing stimuli not only include the nursing stimulus, but light, audition, olfaction, and stress can serve a stimulatory role. Finally, although it is well known that dopamine of hypothalamic origin provides inhibitory control over the secretion of prolactin, other factors within the brain, pituitary gland, and peripheral organs have been shown to inhibit or stimulate prolactin secretion as well. It is the purpose of this review to provide a comprehensive survey of our current understanding of prolactin's function and its regulation and to expose some of the controversies still existing.


Assuntos
Prolactina/metabolismo , Processamento Alternativo/genética , Animais , Mama/efeitos dos fármacos , Mama/metabolismo , Linhagem Celular , Ritmo Circadiano/fisiologia , Feminino , Homeostase/efeitos dos fármacos , Homeostase/fisiologia , Humanos , Linfócitos/metabolismo , Especificidade de Órgãos/efeitos dos fármacos , Especificidade de Órgãos/fisiologia , Adeno-Hipófise/metabolismo , Gravidez , Prolactina/genética , Prolactina/farmacologia , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Isoformas de Proteínas/farmacologia , Receptores da Prolactina/genética , Receptores da Prolactina/metabolismo , Reprodução/efeitos dos fármacos , Reprodução/fisiologia , Transdução de Sinais/fisiologia , Relação Estrutura-Atividade
5.
Endocrinology ; 139(12): 5164-73, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9832457

RESUMO

The aim of this study was to establish the cellular source of ET-like peptides affecting PRL secretion. Fluorescence double label immunocytochemistry and confocal laser scanning microscopy were used to demonstrate cellular colocalization for PRL and endothelin-1 (ET1)-like immunoreactivities in the anterior lobe of the pituitary gland of rats. An ET-specific reverse hemolytic plaque assay was applied to demonstrate that lactotrophs are capable of releasing ET-like peptides. A PRL-specific reverse hemolytic plaque assay was used to assess the influence of the released endogenous ETs on PRL secretion. ET(A)-specific receptor antagonists BQ123 and BQ610, and endothelin convertase enzyme inhibitory peptide, [22Val]big ET1-(16-38), increased PRL secretion, whereas the ET(B) receptor-specific antagonist BQ788 was ineffective. The ET(A) antagonist BQ123-induced increase in PRL secretion followed a bell-shaped dose-response curve in cells obtained from female rats, whereas it followed a sigmoid curve in males. Frequency distribution of PRL plaque sizes using logarithmically binned data revealed two subpopulations of lactotrophs with differential responsiveness to endogenous ETs. These data demonstrate that a large proportion of lactotrophs is capable of expressing and secreting ET-like peptides in biologically significant quantities. As low pituitary cell density in reverse hemolytic plaque assay minimizes cell to cell communications, these findings constitute direct proof of autocrine regulation of PRL secretion by ET-like peptides.


Assuntos
Comunicação Autócrina , Endotelinas/fisiologia , Prolactina/metabolismo , Animais , Comunicação Autócrina/fisiologia , Antagonistas dos Receptores de Endotelina , Feminino , Imuno-Histoquímica , Masculino , Oligopeptídeos/farmacologia , Peptídeos Cíclicos/farmacologia , Adeno-Hipófise/citologia , Adeno-Hipófise/metabolismo , Ratos , Ratos Sprague-Dawley , Receptor de Endotelina A , Caracteres Sexuais
6.
Endocrinology ; 138(8): 3141-53, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9231761

RESUMO

Endothelin-1 (ET-1) inhibits PRL secretion from cultured rat lactotrophs. However, ET-1 stimulates PRL secretion after cultured lactotrophs have been exposed for 48 h to dopamine or D2 dopamine agonists. In the present study, we have used cell-attached and inside-out patch recordings to establish an ionic basis for these effects. Bath application of 20 nM ET-1 to untreated lactotrophs evoked a robust and persistent activation of large-conductance K+ channels in cell-attached patches. This effect of ET-1 had a long latency to onset, was maintained for as long as ET-1 was present, and required at least 10 min of washing in control saline before complete recovery was achieved. The stimulatory effect of 20 nM ET-1 on these channels was markedly attenuated in the presence of the selective ET(A) receptor antagonist BQ-610 (200 nM), or after pertussis toxin (200 ng/ml, 16 h) pretreatment. The unitary slope conductance of the ET-1 activated channels in cell attached patches was 165 and 95 pS when the recording electrodes contained 150 and 5.4 mM KCl, respectively. These channels were voltage-sensitive and their activity increased upon patch depolarization. Previously activated channels in cell-attached patches became quiescent immediately upon patch excision into Ca2+-free bath saline. Exposure of the intracellular surface to 0.1 microM Ca2+ restored the activity of these channels similar to the level seen before patch excision. In addition, preincubating the cells with the membrane-permeable Ca2+-chelator BAPTA-AM, or using Ca2+-free solution in the recording pipettes, prevented the activation of these channels by ET-1. The ET-1 activated large-conductance Ca2+-dependent K+ (BK(Ca)) channels were blocked by 20 mM tetraethylammonium but were insensitive to the K+ channel blockers apamin (1 microM), charybdotoxin (200 nM), or iberiotoxin (200 nM). Acute application of 10 microM dopamine and 20 nM ET-1 caused activation of BK(Ca) channels with indistinguishable kinetic properties, although the effect of dopamine occurred with shorter latency. After 48-h exposure to the specific D2 dopamine receptor agonist (+/-)-2-(N-phenyl-N-propyl) amino-5-hydroxytetralin hydrochloride (PPHT, 500 nM), bath application of 20 nM ET-1 resulted in inhibition of spontaneously active BK(Ca) channels. These data suggest that both the stimulatory and inhibitory effects of ET-1 on PRL secretion are mediated, at least in part, by actions on BK(Ca) channels, and that long term exposure to dopamine or D2 agonists alters the signaling pathways from the ET(A) receptor to BK(Ca) channels.


Assuntos
Agonistas de Dopamina/farmacologia , Endotelinas/farmacologia , Fenetilaminas/farmacologia , Adeno-Hipófise/citologia , Adeno-Hipófise/metabolismo , Canais de Potássio/efeitos dos fármacos , Animais , Apamina/farmacologia , Cálcio/fisiologia , Células Cultivadas , Charibdotoxina/farmacologia , Quelantes/farmacologia , Relação Dose-Resposta a Droga , Ácido Egtázico/análogos & derivados , Ácido Egtázico/farmacologia , Estimulação Elétrica , Antagonistas dos Receptores de Endotelina , Feminino , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Oligopeptídeos/farmacologia , Peptídeos/farmacologia , Toxina Pertussis , Adeno-Hipófise/química , Canais de Potássio/análise , Canais de Potássio/fisiologia , Prolactina/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores de Endotelina/análise , Receptores de Endotelina/fisiologia , Tetraetilamônio , Compostos de Tetraetilamônio/farmacologia , Fatores de Tempo , Fatores de Virulência de Bordetella/farmacologia
7.
Endocrinology ; 136(3): 990-4, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7867609

RESUMO

This study was undertaken to assess the possibility that endothelin-1 (ET-1) and dopamine (DA) can act in concert to modulate PRL secretion. Enzymatically dispersed anterior pituitary cells obtained from random cycling female rats were perifused with Dulbecco's Modified Eagle's Medium supplemented with 0.2% BSA and 100 microM ascorbic acid. In the absence of dopamine, ET-1 (applied at 20 nM for 60 min) rapidly evoked a small transient elevation of PRL release, followed by a sustained inhibitory phase. Overnight perfusion with 500 nM DA-supplemented medium did not change the basic character of ET-1's effects on PRL secretion. Continuation of DA exposure for 48 h dramatically shifted the responsiveness of the lactotrophs to ET-1; the fast stimulatory response was robustly enhanced, whereas the inhibitory phase was replaced by a modest secondary elevation of basal PRL secretion. The stimulatory effect of ET-1 on PRL secretion after DA pretreatment was blocked by an ETA receptor antagonist, BQ-123. The effect of DA can be mimicked completely by a specific D2 receptor agonist (+/-)-2-(N-phenyl-N-propyl)amino-5-hydroxytetraline hydrochloride, whereas pretreatment with a D1 agonist, SKF-39393, failed to change the responsiveness of lactotrophs to ET-1. Our data indicate that persistent activation of D2 receptors, a condition most closely resembling the in vivo environment of the lactotrophs, uncouples the inhibitory signaling pathway from the ETA receptor while synergistically affecting signal transduction, which mediates the ET-induced stimulation of PRL secretion.


Assuntos
Dopamina/farmacologia , Endotelinas/farmacologia , Prolactina/antagonistas & inibidores , Animais , Agonistas de Dopamina/farmacologia , Antagonistas dos Receptores de Endotelina , Feminino , Peptídeos Cíclicos/farmacologia , Adeno-Hipófise/citologia , Adeno-Hipófise/metabolismo , Prolactina/metabolismo , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
8.
Pediatr Res ; 34(6): 742-9, 1993 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8108186

RESUMO

Effects of 2 and 4 micrograms/kg/min dopamine infusion on cardiovascular and renal functions, cerebral blood flow (CBF) and plasma catecholamine levels were studied in sick preterm neonates during the first four days of life. Preterm infants were found to have an enhanced responsiveness to the pressor effects of dopamine during this period. Comparison of the renal effects of 2 and 4 micrograms/kg/min dopamine in 61 preterm infants indicate that 2 micrograms/kg/min dopamine induces maximum diuresis and natriuresis during the first day of life provided that systemic blood pressure is within the predicted normal range. Although administration of 4 micrograms/kg/min dopamine induces further increases in blood pressure and glomerular filtration rate, urine output and sodium excretion remain similar to that on 2 micrograms/kg/min of the drug. These findings demonstrate that the direct tubular effects of dopamine play an important role in the diuretic and natriuretic action of the drug in the one-day old preterm infant. In five preterm neonates, changes in CBF transiently paralleled the dopamine-induced alterations in systemic blood pressure indicating that autoregulation of CBF is impaired but not completely ineffective in the one-day old preterm infant. In eight term neonates, increases in blood pressure had no effect on CBF. Measurements of plasma dopamine and norepinephrine levels in 14 preterm neonates and five children suggest that decreased metabolism of dopamine may contribute to the enhanced pressor responsiveness to dopamine in sick preterm infants.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Sistema Cardiovascular/efeitos dos fármacos , Circulação Cerebrovascular/efeitos dos fármacos , Dopamina/administração & dosagem , Rim/efeitos dos fármacos , Pressão Sanguínea/efeitos dos fármacos , Fenômenos Fisiológicos Cardiovasculares , Circulação Cerebrovascular/fisiologia , Dopamina/sangue , Relação Dose-Resposta a Droga , Hemodinâmica/efeitos dos fármacos , Humanos , Hipotensão/tratamento farmacológico , Recém-Nascido , Recém-Nascido Prematuro , Infusões Intravenosas , Rim/fisiologia , Norepinefrina/sangue , Oligúria/tratamento farmacológico
9.
Am J Physiol ; 265(4 Pt 1): E601-8, 1993 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8238336

RESUMO

To characterize endothelin (ET) receptors modulating pituitary hormone secretion, potencies of ET-like agonists were compared on prolactin (PRL), thyrotropin (TSH), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) secretion from primary cultures of female rat pituitary cells. ET-1 was more potent than ET-3 in all cases. Sarafotoxin (SRTX) S6b an ETA agonist, was also more potent than ET-3 in all cases. SRTX-c, an ETB receptor agonist, was inactive. The ET-1-to-ET-3 potency ratio was three orders of magnitude higher on PRL or TSH secretion than on LH and FSH secretion, whereas SRTX-b-to-ET-3 potency ratios were similar on all four hormones. The ETA antagonist BQ-123 caused a parallel dextral displacement of dose-response curves of ET-1 and ET-3 on all four hormones. Schild regressions for BQ-123 on ET-1-induced PRL, TSH, LH, and FSH secretion indicated that BQ-123 has a similar affinity for the receptors mediating ET-1's effects. When BQ-123 was assessed against ET-3, Schild regressions indicated greater affinity for ET-3 on lactotrophs and thyrotrophs than gonadotrophs. Thus changes in pituitary hormone secretion are mediated by ETA-like receptors. ET receptors in lactotrophs and thyrotrophs are clearly distinguishable from gonadotrophs. We suggest the existence of distinct ETA receptor subtypes (ETA1 and ETA2) on these differing pituitary cells.


Assuntos
Adeno-Hipófise/metabolismo , Receptores de Endotelina/metabolismo , Animais , Células Cultivadas , Antagonistas dos Receptores de Endotelina , Endotelinas/antagonistas & inibidores , Endotelinas/farmacologia , Feminino , Peptídeos Cíclicos/farmacologia , Adeno-Hipófise/citologia , Hormônios Adeno-Hipofisários/metabolismo , Ratos , Venenos de Víboras/farmacologia
10.
Endocrinology ; 129(5): 2607-13, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1935791

RESUMO

Different bacterial toxins capable of modifying specific alpha-subunits of G-proteins were used to characterize the guanine nucleotide-binding protein (G-protein) dependency of the effects of endothelins (ETs) on PRL, LH, and FSH secretion. Primary cultures of anterior pituitary cells obtained from female rats were preincubated for 24 h with 20 ng/ml pertussis toxin (PTX) or 2 micrograms/ml cholera toxin (CTX) before challenge with ETs. Both ET-1 and ET-3 elicited a concentration-dependent inhibition of PRL secretion and stimulated the release of LH and FSH secretion on pituitary cells not treated with toxins. Based on the calculated ration of the half-maximal effective concentrations (EC50) of ET-1 and ET-3, ET-1 showed 7800, 20, and 14 times greater potency than ET-3 on PRL, LH, and FSH secretion, respectively. PTX, a selective inhibitor of Gi and several other G proteins, increased the basal secretion of PRL and completely eliminated the responsiveness of lactotroph cells to ET-1 and ET-3. Pretreatment with PTX caused a markedly different effect on LH and FSH secretion: while basal LH release was slightly increased, FSH secretion was markedly depressed by PTX. Moreover, while ET-induced LH secretion was enhanced by PTX, the effectiveness of ETs on FSH release was completely abolished. CTX, known as an activator of Gs proteins, decreased the basal secretory activity of lactotrophs but did not influence the ET-induced decrease of PRL release. CTX pretreatment (like PTX before) elicited a strikingly different effect on LH and FSH: while basal LH secretion was enhanced, basal FSH secretion was markedly inhibited by CTX. Moreover, while the effectiveness of ETs on LH secretion was not changed significantly, the stimulatory effect of ETs on FSH secretion was diminished after CTX pretreatment. Thus, the inhibition of PRL secretion by ETs requires a PTX-sensitive G protein while the ET-induced stimulation of FSH secretion involves both PTX- and CTX-sensitive elements. The fact that pretreatments with PTX or CTX influenced basal secretion of PRL, LH, and FSH suggests that PTX- and/or CTX-sensitive G proteins are directly involved in the process of exocytosis. Additionally, these findings might indicate an active paracrine/autocrine regulation of pituitary cells in culture that are impaired or enhanced by the bacterial toxins employed. Though the broad substrate specificity of PTX and CTX and the multiplicity of G protein families did not allow us to identify the specific G protein(s) involved, these data reveal the diversity of ET-induced intracellular signaling mechanisms in lactotrophs and gonadotrophs.


Assuntos
Endotelinas/farmacologia , Hormônio Foliculoestimulante/metabolismo , Proteínas de Ligação ao GTP/fisiologia , Hormônio Luteinizante/metabolismo , Prolactina/metabolismo , Animais , Toxina da Cólera/farmacologia , Relação Dose-Resposta a Droga , Feminino , Toxina Pertussis , Ratos , Ratos Endogâmicos , Fatores de Virulência de Bordetella/farmacologia
11.
Eur J Pharmacol ; 198(2-3): 223-5, 1991 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-1907563

RESUMO

The effect of pertussis toxin (PTX) pretreatment on endothelin-3 (ET-3)-mediated inhibition of prolactin secretion from primary cultures of rat anterior pituitary cells was examined. Monolayer cultures of anterior pituitary cells were treated with either 20 ng/ml PTX dissolved in media or with media alone (control) on the third day of culture. Exactly 24 h after PTX pretreatment, cells were challenged with either 100 nM ET-3 dissolved in media or media alone (control) for 4 or 48 h. ET-3 significantly (P less than 0.01) inhibited prolactin secretion in both the 4 and 48 h incubations. However, if the cells had been previously treated with PTX, ET-3 did not significantly affect prolactin secretion. These data suggest that a PTX-sensitive G protein mediates ET-3-induced inhibition of prolactin secretion and that ET-3 may invoke a signal transduction mechanism in the lactotroph which is distinct from those described in other cell types.


Assuntos
Endotelinas/farmacologia , Toxina Pertussis , Adeno-Hipófise/metabolismo , Prolactina/metabolismo , Fatores de Virulência de Bordetella/farmacologia , Animais , Células Cultivadas , Feminino , Proteínas de Ligação ao GTP/metabolismo , Adeno-Hipófise/citologia , Adeno-Hipófise/efeitos dos fármacos , Radioimunoensaio , Ratos , Transdução de Sinais
12.
Neuroendocrinology ; 53(1): 35-40, 1991 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2046860

RESUMO

Prolactin (PRL) secretion in the female rat is regulated by an endogenous stimulatory rhythm (ESR), which is normally under the tonic inhibition of dopamine (DA). The ESR consists of a nocturnal (N) component which peaks at approximately 03.00 h, and a diurnal (D) component which peaks at approximately 17.00 h. This ESR has been shown to be present in ovariectomized and cervically stimulated rats. We have proposed that the ESR is continuously present in the female rat and that any suppression of the tonic inhibitory influence on PRL secretion can reveal its existence. In this study, the effects of the DA-lowering stimulus of suckling was investigated at different times of day in lactating rats. In addition, the pattern of PRL secretion in freely lactating rats throughout a 24-hour period was studied. Female rats were separated from their pups for 6 h prior to reunion at either 03.00 (coincident with the N component), 12.00 (control) or 17.00 h (coincident with the D component) at various stages of lactation. Blood samples were collected from intra-atrial cannulae immediately before separation of pups and dams, immediately before reunion of pups and dams (0 time), and 15, 30, 60 and 120 min following reunion of pups and dams. Four days following parturition, dams suckled at either 03.00 or 17.00 h secreted significantly greater PRL than rats suckled at 12.00 h. Peak levels of PRL were 60-, 90- and 25-fold greater than 0 time levels, at 03.00, 17.00 and 12.00 h, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Ritmo Circadiano , Lactação/fisiologia , Prolactina/metabolismo , Animais , Dopamina/fisiologia , Feminino , Hormônio do Crescimento/metabolismo , Ocitocina/metabolismo , Ratos , Ratos Endogâmicos
13.
Biochem Biophys Res Commun ; 174(1): 338-43, 1991 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-1899191

RESUMO

The influence of endothelin-3 (ET-3) on anterior pituitary hormone secretion was investigated over a wide range of concentrations (from 10(-14) to 10(-6) M) and incubation times (from 4 to 48 hours). ET-3 elicited a concentration-dependent inhibition of prolactin (PRL) secretion and stimulated the release of luteinizing hormone (LH), follicle stimulating hormone (FSH) and thyroid stimulating hormone (TSH) from primary monolayer cultures of anterior pituitary cells derived from female rats. The responsiveness of different pituitary cells to ET-3 differs markedly in terms of onset and duration: the maximal inhibition of PRL secretion occurred after 12 hours and the stimulation of LH, FSH and TSH reached the maximum after 4, 48 and 48 hours of incubation, respectively. These data corroborate the concept that ET-3 has an important role as a neuroendocrine modulator. Moreover, the data presented suggest different intracellular mechanisms underlying ET-3 actions.


Assuntos
Endotelinas/farmacologia , Hormônio Foliculoestimulante/metabolismo , Adeno-Hipófise/metabolismo , Prolactina/metabolismo , Tireotropina/metabolismo , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Endotelinas/administração & dosagem , Feminino , Cinética , Adeno-Hipófise/efeitos dos fármacos , Ratos
14.
Endocrinology ; 126(4): 2021-6, 1990 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2318155

RESUMO

The contribution of the uterus to the regulation of PRL secretion in lactating dams and cycling female rats was investigated. Lactating animals were hysterectomized or sham operated 2 days after parturition, and the number of pups was adjusted to eight. Blood samples for PRL RIA were obtained through intra-atrial cannulae implanted 2 days before experimentation. In order to study the PRL secretory profile in undisturbed freely lactating rats, blood samples were taken every 2 h for 24 h starting at 1400 h. During early lactation (days 7-8), hysterectomy did not alter the PRL secretory profile compared to that of sham-operated controls. On days 14-15 post partum, PRL secretion followed a characteristic bimodal pattern showing two PRL surges at 1800 h and 0600 h. After hysterectomy, the early morning PRL surge disappeared and PRL secretion showed an unimodal daily rhythm reaching its peak at 1800 h. The possible effect of the absence of the uterus on suckling-induced PRL release at various stages of lactation was studied. On days 7-8, suckling stimuli after 4 h of pup deprivation induced robust PRL release. Hysterectomy did not significantly alter PRL release at this earlier stage of lactation. In control groups, the suckling-induced PRL secretory response markedly declined as the postpartum period advanced. On the other hand, the hysterectomized animals retained significantly greater responsiveness to suckling during the second half of lactation. These data indicate an inhibitory influence of the uterus on PRL secretion. The onset of this uterine effect is considerably delayed, and its influence became prominent only at a later phase of lactation. The effect of length of pup deprivation preceding the suckling stimulus, in combination with hysterectomy, was also investigated. Hysterectomy significantly increased suckling-induced PRL release after 4 and 24 h separation compared to the sham-hysterectomized animals. When the separation was longer than 48 h, the inducibility of PRL release by suckling declined and was not influenced by hysterectomy. In order to study the possible influence of the uterus on PRL secretion during the estrous cycle, regularly cycling female rats were hysterectomized at diestrus 1. Twelve days later the animals were cannulated, and serial blood samples were taken during the subsequent proestrus. Hysterectomy did not alter the PRL surge which occurred on the afternoon of proestrus indicating that the uterus does not have a major function in regulating PRL secretion on proestrus. In conclusion, hysterectomy significantly delayed the extinction of suckling-induced PRL release revealing the active role of the uterus in the regulation of this neuroendocrine reflex.


Assuntos
Histerectomia , Lactação/metabolismo , Prolactina/metabolismo , Animais , Feminino , Gravidez , Proestro/metabolismo , Ratos , Ratos Endogâmicos
15.
J Pharmacol Exp Ther ; 250(1): 72-8, 1989 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2746512

RESUMO

The serotonin (5-HT) agonist, m-chlorophenylpiperazine (m-CPP), has been shown to increase blood pressure (BP), heart rate (HR), plasma catecholamine and prolactin (PRL) concentrations and to cause hypoactivity in rodents. In the present study, we used selective 5-HT and adrenergic antagonists to study the involvement of different receptor subtypes on the effects of m-CPP in conscious, freely moving rats. Hypoactivity and PRL responses were blocked by pretreatment with metergoline but not by pretreatment with other antagonists. BP increases were antagonized by ritanserin (0.1, 0.63 and 2.0 mg/kg) and ketanserin; metergoline, xylamidine or prazosin pretreatment had only partial effects on BP responses. HR increases were antagonized by yohimbine, pindolol, ketanserin and by the two higher doses of ritanserin. After pretreatment with the two higher doses of ritanserin, m-CPP decreased markedly BP and HR. These decreases were prevented by metergoline pretreatment. Norepinephrine and epinephrine responses were dose-dependently attenuated by ritanserin; naloxone pretreatment attenuated epinephrine but not norepinephrine responses. These data suggest that hypoactivity, PRL responses, and cardiodepressive effects of m-CPP are mediated by 5-HT1 receptors. It is likely that the hypoactivity and PRL responses of m-CPP are mediated by 5-HT1B receptors, and the cardiodepressive effects by 5-HT1A receptors. Increases in BP appear to be primarily mediated by stimulation of 5-HT2 receptors. Both adrenergic and serotonergic mechanisms are involved in HR responses. The catecholamine responses to m-CPP appear to be partially mediated by 5-HT1C receptors and also by nonserotonergic mechanisms.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Epinefrina/sangue , Frequência Cardíaca/efeitos dos fármacos , Norepinefrina/sangue , Piperazinas/farmacologia , Prolactina/sangue , Receptores de Serotonina/fisiologia , Antagonistas da Serotonina/farmacologia , Animais , Cinética , Masculino , Prolactina/metabolismo , Ratos , Ratos Endogâmicos , Receptores de Serotonina/efeitos dos fármacos , Valores de Referência
16.
Neuroendocrinology ; 48(2): 174-9, 1988 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2906115

RESUMO

Cortisol administered at a dose of 25 mg/kg 24 h before measurements decreased the prolactin secretion induced by intraventricularly given opioids (dynorphin, beta-endorphin, Met-enkephalin or D-Met-Pro-enkephalinamide). The effect of cortisol was depressed by actinomycin D pretreatment. The cortisol-induced inhibition of the action of morphine was facilitated in adrenalectomized animals; measuring the effects of increasing doses of cortisol a maximal inhibition was obtained at a dose of 5 mg/kg. The opioid-induced corticosterone secretion was not affected 24 h after a single administration of cortisol. The present results show that the cortisol-induced inhibition of opioid-induced prolactin secretion is dependent on protein synthesis and independent of changes in drug metabolism, and of the type of opiate receptor preferentially affected by the opiate agonists employed.


Assuntos
Adrenalectomia , Ventrículos Cerebrais/fisiologia , Endorfinas/farmacologia , Hidrocortisona/farmacologia , Prolactina/metabolismo , Animais , Ventrículos Cerebrais/efeitos dos fármacos , Dinorfinas/farmacologia , Endorfinas/administração & dosagem , Encefalina Metionina/análogos & derivados , Encefalina Metionina/farmacologia , Injeções Intraventriculares , Masculino , Prolactina/sangue , Ratos , Ratos Endogâmicos , Valores de Referência , beta-Endorfina/farmacologia
17.
Biochem Pharmacol ; 37(4): 749-52, 1988 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-2829923

RESUMO

Phenylethanolamine-N-methyltransferase (PNMT) activity and tissue catecholamine content were examined after 13 days morphine treatment. Prolonged morphine treatment did not alter the PNMT activity in brain regions (A1/C1 and A2/C2 cell groups, medial basal hypothalamus, median eminence). However, the enzyme activity and the adrenaline content were increased in the adrenal medulla of male rats. In parallel, morphine treatment induced adrenal hypertrophy. In female or hypophysectomized male animals the chronic morphine treatment had no effect on adrenal weight but evoked the increase of PNMT activity. It is concluded that the morphine-induced increased adrenaline biosynthesis in the adrenal gland is not fully dependent on the intact pituitary-adrenal axis and may be mediated partly by a neural mechanism (increased splanchnic nerve activity) or by a direct effect of morphine.


Assuntos
Glândulas Suprarrenais/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Epinefrina/biossíntese , Morfina/farmacologia , Glândulas Suprarrenais/metabolismo , Hormônio Adrenocorticotrópico/farmacologia , Animais , Encéfalo/metabolismo , Feminino , Masculino , Feniletanolamina N-Metiltransferase/análise , Ratos , Ratos Endogâmicos
18.
Neuroendocrinology ; 46(6): 475-80, 1987 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2892145

RESUMO

Diurnal variations of the effectivity of beta-endorphin (beta-End), dynorphin (DYN), Met-enkephalin (Met-Enk), D-Met2-Pro5-enkephalinamide (D-Met-Pro-Enk) and morphine to induce prolactin (PRL) and adrenocorticotropin (ACTH)/corticosterone (CS) release in intact and adrenalectomized rats have been examined. The response to morphine (10 mg/kg s.c.), Met-Enk (200 micrograms/rat i.c.v.) and D-Met-Pro-Enk (0.5 microgram/rat i.c.v.) did not change with different times of the day, while that to beta-End (0.5 microgram/rat i.c.v.), DYN (1 microgram/rat i.c.v.) and U50-488H, a selective kappa agonist (10 mg/kg s.c.), showed a circadian rhythm in stimulating PRL release, with a higher increase in the afternoon (16.00-17.00 h) than in the morning (08.00-09.00 h). In adrenalectomized rats the loss of this circadian rhythm was shown. The CS release evoked by morphine, D-Met-Pro-Enk, Met-Enk and DYN was demonstrable only in the morning when the basal CS level was significantly lower than in the afternoon. The afternoon release of ACTH by morphine was higher than in the morning in adrenalectomized rats. beta-End and U50-488H were equally active in the morning and in the afternoon in increasing CS secretion. The present results suggest that the diurnal rhythm in the response of CS and PRL release to opioids is in relation with the glucocorticoid secretion.


Assuntos
Hormônio Adrenocorticotrópico/metabolismo , Ritmo Circadiano/efeitos dos fármacos , Corticosterona/metabolismo , Endorfinas/farmacologia , Morfina/farmacologia , Prolactina/metabolismo , (trans)-Isômero de 3,4-dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclo-hexil)-benzenoacetamida , Adrenalectomia , Analgésicos/farmacologia , Animais , Dinorfinas/farmacologia , Encefalina Metionina/análogos & derivados , Encefalina Metionina/farmacologia , Masculino , Fragmentos de Peptídeos/farmacologia , Pirrolidinas/farmacologia , Ratos , Ratos Endogâmicos , beta-Endorfina/farmacologia
19.
Biochem Biophys Res Commun ; 144(3): 1214-21, 1987 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-3555499

RESUMO

New agonists related to gonadotropin-releasing hormone (GnRH) have been synthesized that are comparable in potency to the GnRH and its superagonists for release of LH and estrus suppression without substitutions with D- or unnatural amino acids in position 6. We now report a series of L-beta-aspartyl-6 GnRH analogs containing only naturally occurring L-amino acids in the whole sequence, exhibiting considerable in vivo biological activity. Dose and time dependent LH release capability of the different analogs in adult male mice, estrus suppression comparisons and blockade of ovulation in female rats are given. The incorporation of L-Asp-OMe and L-Asp-OBzl in position 6 of GnRH resulted in the most potent GnRH agonists (to 12-20xGnRH potency) in this series inducing a biphasic biological response similar to the D-amino acid-6 substituted superactive GnRH analogs. A correlation between the LH releasing potencies of the analogs and their HPLC retention times was also investigated. Peptide synthesis were achieved using either solid phase or solution phase methodology.


Assuntos
Hormônio Liberador de Gonadotropina/análogos & derivados , Hormônio Liberador de Gonadotropina/síntese química , Animais , Feminino , Hormônio Liberador de Gonadotropina/farmacologia , Indicadores e Reagentes , Hormônio Luteinizante/metabolismo , Masculino , Camundongos , Ovulação/efeitos dos fármacos , Relação Estrutura-Atividade
20.
Endocrinol Exp ; 20(2-3): 217-22, 1986 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-3489597

RESUMO

The effects of separation and suckling on serum growth hormone (GH) levels of lactating rats and their pups were studied on days 1-3 of lactation. The litter size was adjusted to 8 pups/dam without respect to sex. The separation of pups from their mother for 5 h resulted in significant decrease in GH level in the pups. After 30 or 60 min of suckling the level of GH in serum of the pups reached the values of the control group, i.e. non-separated pups. If the pups were attached to pre-suckled mothers, thus consuming less milk, their serum GH levels increased in a significantly lesser extent. It is concluded that some factor(s) are present in milk which stimulate(s) GH secretion of the pups. Due to episodic secretion, high standard error occurred in every group of mothers studied. Mean GH level of freely behaving lactating rats were rather constant. On the other hand, the 5 h separation period and 30 min of suckling seemed to result in decrease and increase in serum GH values, respectively. By the end of a 60 min suckling period, GH declined to low levels again, hence it is likely that the separation and suckling stimuli synchronized GH-episodes. When the litter was replaced with hungry foster pups at 30 min of suckling, GH-decay by 60 min appeared to be less consequent.


Assuntos
Animais Lactentes/fisiologia , Hormônio do Crescimento/sangue , Animais , Feminino , Privação Materna , Leite/metabolismo , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...